Inotuzumab ozogamicin Intravenous and Selegiline transdermal
Determining the interaction of Inotuzumab ozogamicin Intravenous and Selegiline transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: Selegiline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Selegiline Transdermal System
- Inotuzumab ozogamicin Intravenous-Selenicaps-200
- Inotuzumab ozogamicin Intravenous-Selenimin
- Inotuzumab ozogamicin Intravenous-Selenimin-200
- Inotuzumab ozogamicin Intravenous-Selenious Acid
- Inotuzumab ozogamicin Intravenous-Selenious Acid Injection
- Selegiline transdermal-Inova
- Selegiline transdermal-Inova 4/1 topical
- Selegiline transdermal-Inova 8/2 topical
- Selegiline transdermal-Inova ACT
- Selegiline transdermal-Inrebic
- Selegiline transdermal-Inspra